Article
Retinal specialists have reason to be excited this year, especially in the arena of developing treatments for age-related macular degeneration (AMD). In contrast to roughly 5 years ago, when only laser was available to arrest progression of extrafoveal vessels, now an array of approaches is on the horizon.
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.